Compare AU

Compare CURE vs. ERTH

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the BetaShares Climate Change Innovation ETF (ERTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

ERTH

Popularity

Low

Low

Pearlers invested

82

370

Median incremental investment

$619.50

$602.01

Median investment frequency

Monthly

Monthly

Median total investment

$1,323.41

$926.17

Average age group

> 35

26 - 35


Key Summary

CURE

ERTH

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

ERTH.AX was created on 2021-03-09 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. ERTH.AX aims to track the performance of an index (before fees and expenses) that comprises a portfolio of up to 100 leading global companies that derive at least 50% of their revenues from products and services that help to address climate change and other environmental problems through the reduction or avoidance of CO2 emissions.

Top 3 holdings

Natera Inc (3.41 %)

Incyte Corp (2.94 %)

Gilead Sciences Inc (2.88 %)

CIE DE SAINT-GOBAIN (5.14 %)

ECOLAB INC (5.08 %)

DSM-FIRMENICH AG (4.97 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Other (56.07 %)

Information Technology (10.82 %)

Consumer Discretionary (9.83 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

United States (40.06 %)

China (11.65 %)

Denmark (7.67 %)

Management fee

0.45 %

0.55 %


Key Summary

CURE

ERTH

Issuer

Global X

BetaShares

Tracking index

S&P Biotechnology Select Industry

Solactive Climate Change and Environmental Opportunities Index - AUD - Benchmark TR Net

Asset class

ETF

ETF

Management fee

0.45 %

0.55 %

Price

$49.94

$9.28

Size

$38.065 million

$96.548 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

4.24 %

0.58 %

Market

ASX

ASX

First listed date

12/11/2018

10/03/2021

Purchase fee

$6.50

$6.50


Community Stats

CURE

ERTH

Popularity

Low

Low

Pearlers invested

82

370

Median incremental investment

$619.50

$602.01

Median investment frequency

Monthly

Monthly

Median total investment

$1,323.41

$926.17

Average age group

> 35

26 - 35


Pros and Cons

CURE

ERTH

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher distribution yield

  • Higher price growth

Cons

  • Lower price growth

  • Lower exposure to US market

  • Higher management fee

  • Lower distribution yield

CURE

ERTH

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home